PROVIDER PROFILE · NPI 1407071467

Homayoun AtaeiM.D.

Family PracticeHouston, TXI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$367

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Atorvastatin Calcium26 claims

Amlodipine Besylate20 claims

Ibuprofen11 claims

QUALITY · MIPS · 2024

Final MIPS score

92.9

Quality

87.8

Cost

76.2

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.75%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Homayoun Ataei's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Houston, TX	23	53
Westchase Imaging Ltd Independent Diagnostic Testing Facility (IDTF) · Houston, TX	17	61

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history